Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,052,991
  • Shares Outstanding, K 56,291
  • Annual Sales, $ 634,440 K
  • Annual Income, $ -25,510 K
  • EBIT $ 10 M
  • EBITDA $ 95 M
  • 60-Month Beta 1.13
  • Price/Sales 11.35
  • Price/Cash Flow 46.22
  • Price/Book 3.88

Options Overview Details

View History
  • Implied Volatility 53.58% (-0.07%)
  • Historical Volatility 32.60%
  • IV Percentile 76%
  • IV Rank 36.02%
  • IV High 84.92% on 04/07/25
  • IV Low 35.94% on 08/14/25
  • Expected Move (DTE 9) 8.67 (6.21%)
  • Put/Call Vol Ratio 9.71
  • Today's Volume 75
  • Volume Avg (30-Day) 111
  • Put/Call OI Ratio 1.75
  • Today's Open Interest 7,055
  • Open Int (30-Day) 7,070
  • Expected Range 130.84 to 148.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.44
  • Number of Estimates 6
  • High Estimate 0.46
  • Low Estimate 0.42
  • Prior Year 0.44
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
137.46 +0.89%
on 02/11/26
174.87 -20.70%
on 01/22/26
-28.14 (-16.87%)
since 01/09/26
3-Month
137.46 +0.89%
on 02/11/26
175.77 -21.10%
on 01/06/26
-14.76 (-9.62%)
since 11/11/25
52-Week
102.96 +34.69%
on 04/07/25
175.77 -21.10%
on 01/06/26
-10.81 (-7.23%)
since 02/11/25

Most Recent Stories

More News
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results

WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter 2025 financial results on Tuesday, February 24, 2026....

RGEN : 138.31 (-3.32%)
3 Volatile Stocks Walking a Fine Line

3 Volatile Stocks Walking a Fine Line

GETY : 1.0750 (-6.52%)
RGEN : 138.31 (-3.32%)
JLL : 311.75 (-9.96%)
2 Cash-Producing Stocks to Target This Week and 1 We Ignore

2 Cash-Producing Stocks to Target This Week and 1 We Ignore

MRK : 118.39 (+1.06%)
RGEN : 138.31 (-3.32%)
URBN : 70.74 (+0.43%)
3 Reasons to Sell RGEN and 1 Stock to Buy Instead

3 Reasons to Sell RGEN and 1 Stock to Buy Instead

RGEN : 138.31 (-3.32%)
3 High-Flying Stocks That Fall Short

3 High-Flying Stocks That Fall Short

CGNX : 43.49 (-0.21%)
PEN : 339.74 (+0.23%)
RGEN : 138.31 (-3.32%)
Why Repligen (RGEN) Shares Are Sliding Today

Why Repligen (RGEN) Shares Are Sliding Today

RGEN : 138.31 (-3.32%)
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair

WALTHAM, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Board has elected...

RGEN : 138.31 (-3.32%)
1 Cash-Heavy Stock to Target This Week and 2 Facing Challenges

1 Cash-Heavy Stock to Target This Week and 2 Facing Challenges

RGEN : 138.31 (-3.32%)
PINS : 19.27 (-5.21%)
MANH : 143.65 (-4.00%)
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate...

RGEN : 138.31 (-3.32%)
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new...

RGEN : 138.31 (-3.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies. Repligen earns revenues from the...

See More

Key Turning Points

3rd Resistance Point 150.79
2nd Resistance Point 148.57
1st Resistance Point 145.82
Last Price 138.31
1st Support Level 140.85
2nd Support Level 138.63
3rd Support Level 135.88

See More

52-Week High 175.77
Fibonacci 61.8% 147.96
Fibonacci 50% 139.37
Last Price 138.31
Fibonacci 38.2% 130.77
52-Week Low 102.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar